All Cancer articles – Page 9
-
Business
Clinical collaborations drive cancer immunotherapy
Companies race to pair up chemotherapy drugs with immune system-boosting antibodies to greatest effect in trials
-
Business
Illumina targets cancer diagnostics
Sequencing will improve tests and speed up clinical trials processes for big pharma partners
-
ResearchRadiolabels help evaluate emerging cancer treatment
Tracking tools will aid transition of boron neutron capture therapy from bench to hospital
-
Business
First of a new breed of anticancer antibodies approved in Japan
Ono claims Opdivo is the first anti-PD1 treatment in the world
-
Business
Genentech to buy breast cancer specialist Seragon
$1.7bn deal for hormone receptor-destroying drug pipeline
-
BusinessPharma vies to unleash immune system power on cancer
Immuno-oncological drugs look set to earn billions and significantly lengthen patients’ lives
-
Research
Pre-childbirth solvent exposure raises breast cancer risk
Women working with solvents before having children are more at risk
-
ResearchElemental discoveries at the cellular level
The concentrations of vital chemical elements in cancer cells has been mapped using a dual technique
-
Business
Merck & Co doubles up on Ablynx research deal
Cancer nanobody R&D partnership could be worth €1.7 billion
-
Business
Pfizer teams up with GSK in cancer drug trial
Two companies will collaborate to develop a combination therapy for melanoma
-
News
£100 million for cancer research centres
Money will fund 15 research centres and 200 PhDs to target the hardest cancers to beat
-
-
Business
Amgen snaps up Onyx in huge biotech deal
$10.4 billion acquisition will expand firm’s oncology portfolio
-
Business
Nice rules against Afinitor
Novartis’ drug will not routinely be available on the UK health service
-
News
Chinese scientist sentenced over research theft
Researcher working at US university given time served for charges relating to disappearance of vials of promising drug candidate
-
Business
NHS to offer breast cancer prevention drugs
Five-year course of tamoxifen or raloxifene recommended for high risk women
-
NewsUS supreme court rules genes can't be patented
Breast cancer test company at centre of case can still rely on patents on non-naturally occurring DNA
-
NewsFukushima disaster has not raised cancer risks, says UN
Latest study at odds with others that predicted a slight increase in certain types of tumours
-
Business
Two new ‘personalised’ cancer drugs approved
Suitable patients for GSK’s melanoma treatments must be identified using an accompanying genetic test